Additionally, Quanterix’s Simoa platform will be featured in over ... Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have ...
Quanterix Corporation , a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the inclusion of a new dried blood spot extraction (DBS) kit as part of their ...
Quanterix sees growth with Akoya acquisition, but rising losses and investor skepticism persist. Explore challenges and ...
Validation studies show that DBS samples from two different devices tested with Simoa ALZpath p-Tau 217 and the Simoa extraction kit demonstrated correlation to venous in simulated CSF spiked ...
--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the inclusion of a new dried blood spot ...